BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 28370546)

  • 1. Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy.
    Li X; Kim J; Yoon J; Chen X
    Adv Mater; 2017 Jun; 29(23):. PubMed ID: 28370546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
    Gomes Marin JF; Nunes RF; Coutinho AM; Zaniboni EC; Costa LB; Barbosa FG; Queiroz MA; Cerri GG; Buchpiguel CA
    Radiographics; 2020 Oct; 40(6):1715-1740. PubMed ID: 33001789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimuli-activatable nanomedicine meets cancer theranostics.
    Li H; Feng Y; Luo Q; Li Z; Li X; Gan H; Gu Z; Gong Q; Luo K
    Theranostics; 2023; 13(15):5386-5417. PubMed ID: 37908735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application and Importance of Theranostics in the Diagnosis and Treatment of Cancer.
    Jeyamogan S; Khan NA; Siddiqui R
    Arch Med Res; 2021 Feb; 52(2):131-142. PubMed ID: 33423803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review on Metal-Based Theranostic Nanoparticles for Cancer Therapy and Imaging.
    Fernandes DA
    Technol Cancer Res Treat; 2023; 22():15330338231191493. PubMed ID: 37642945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium theranostics for the diagnosis and treatment of cancer.
    Robertson AG; Rendina LM
    Chem Soc Rev; 2021 Apr; 50(7):4231-4244. PubMed ID: 33599224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of G-quadruplex topology through hybrid binding with implications in cancer theranostics.
    Suseela YV; Satha P; Murugan NA; Govindaraju T
    Theranostics; 2020; 10(23):10394-10414. PubMed ID: 32929356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart magnetic resonance imaging-based theranostics for cancer.
    Brito B; Price TW; Gallo J; Bañobre-López M; Stasiuk GJ
    Theranostics; 2021; 11(18):8706-8737. PubMed ID: 34522208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional gadolinium-based nanoscale systems for cancer theranostics.
    Li H; Zeng Y; Zhang H; Gu Z; Gong Q; Luo K
    J Control Release; 2021 Jan; 329():482-512. PubMed ID: 32898594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-Actuated Turn-On Theranostic Nanoplatforms for Imaging-Guided Antibacterial Treatment.
    Yang S; Song Y; Dong H; Hu Y; Jiang J; Chang S; Shao J; Yang D
    Small; 2023 Dec; 19(52):e2304127. PubMed ID: 37649207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Photosensitizers as Multifunctional Theranostic Agents for Imaging-Guided Photodynamic Therapy of Cancer.
    Sarbadhikary P; George BP; Abrahamse H
    Theranostics; 2021; 11(18):9054-9088. PubMed ID: 34522227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfide-based multifunctional conjugates for targeted theranostic drug delivery.
    Lee MH; Sessler JL; Kim JS
    Acc Chem Res; 2015 Nov; 48(11):2935-46. PubMed ID: 26513450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-Stimuli Responsive Nanotheranostics for Multimodal Imaging Guided Trimodal Synergistic Therapy.
    Fang S; Lin J; Li C; Huang P; Hou W; Zhang C; Liu J; Huang S; Luo Y; Fan W; Cui D; Xu Y; Li Z
    Small; 2017 Feb; 13(6):. PubMed ID: 27862953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activatable dual-functional molecular agents for imaging-guided cancer therapy.
    Zhang P; Zhu Y; Xiao C; Chen X
    Adv Drug Deliv Rev; 2023 Apr; 195():114725. PubMed ID: 36754284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine.
    Moorthy H; Govindaraju T
    ACS Appl Bio Mater; 2021 Feb; 4(2):1115-1139. PubMed ID: 35014470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Nanoliposomes as in Situ Microbubble Bombers for Multimodality Image-Guided Cancer Theranostics.
    Liu Y; Yang F; Yuan C; Li M; Wang T; Chen B; Jin J; Zhao P; Tong J; Luo S; Gu N
    ACS Nano; 2017 Feb; 11(2):1509-1519. PubMed ID: 28045496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.
    Chen Z; Krishnamachary B; Pachecho-Torres J; Penet MF; Bhujwalla ZM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1595. PubMed ID: 31642207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fast-growing field of photo-driven theranostics based on aggregation-induced emission.
    Zhang Z; Kang M; Tan H; Song N; Li M; Xiao P; Yan D; Zhang L; Wang D; Tang BZ
    Chem Soc Rev; 2022 Mar; 51(6):1983-2030. PubMed ID: 35226010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
    Cai Y; Chen X; Si J; Mou X; Dong X
    Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the development of nanoparticles for multimodality imaging and therapy of cancer.
    Liu M; Anderson RC; Lan X; Conti PS; Chen K
    Med Res Rev; 2020 May; 40(3):909-930. PubMed ID: 31650619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.